Dermofural-diabetic foot ulcers

Phase 2

• Conditions: Diabetic foot ulcers; Diabetic Foot; Foot Ulcer; Diabetic Angiopathies; Diabetic Neuropathies; Diabetes Mellitus; Diabetes Complications; Leg Ulcer; Endocrine System Diseases; Skin Ulcer

• Registration Number: RPCEC00000211
• Lead Sponsor: Chemical Bioactive Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-03-11
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 37

Inclusion Criteria

1. Patients who meet the established diagnostic criteria.
2. Patients older than 18 years.
3. Patients express voluntary by signing the informed consent to participate in research and completing the set exams.

Exclusion Criteria

1. Pregnancy, postpartum or breastfeeding.
2. History of allergy or hypersensitivity to Dermofural or any of its components.
3. Patients suffering or concern clinically determined by the physician either decompensated chronic illness.
4. Patients being treated with immunotherapy or other cancer treatment or who have received in the last three months prior to this study.
5. Patients with serious psychiatric disorders or mental disability that prevents him expressing their willingness to participate in the study or evaluation difficult.
6. Patients who are or have been recently involved (1 month) in another study.
7. Patients with other active infections requiring the use of antibacterial agents during the study.
8. Patients who have received systemic antibacterial therapy in the 72 hours before the start of the study.
9. Patients with more than one diabetic foot ulcer.

Study & Design

• Study Type: Interventional
• Study Design: Not specified